USD 0.04
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 401.49 Thousand USD | 97.24% |
2022 | 203.55 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | -100.0% |
2024 Q1 | 92.87 Thousand USD | 1726.28% |
2023 Q3 | 165.3 Thousand USD | 39.67% |
2023 FY | 401.49 Thousand USD | 97.24% |
2023 Q4 | -5711.00 USD | -103.45% |
2023 Q1 | 123.53 Thousand USD | 80.76% |
2023 Q2 | 118.36 Thousand USD | -4.19% |
2022 Q2 | 88.37 Thousand USD | 698.64% |
2022 Q1 | 11.06 Thousand USD | 0.0% |
2022 FY | 203.55 Thousand USD | 0.0% |
2022 Q4 | 68.34 Thousand USD | 45.9% |
2022 Q3 | 46.84 Thousand USD | -46.99% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BioQuest Corp. | - USD | -Infinity% |
Clever Leaves Holdings Inc. | 17.41 Million USD | 97.695% |
Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 99.873% |
Guardion Health Sciences, Inc. | 12.24 Million USD | 96.722% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | - USD | -Infinity% |
Instadose Pharma Corp. | - USD | -Infinity% |